US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.8349

+0.01491.82%

Post-market: 0.7800-0.0549-6.58%19:29 EDT

Volume:477.71K

Turnover:403.07K

Market Cap:27.71M

PE:-0.33

High:0.9000

Open:0.8231

Low:0.7862

Close:0.8200

Loading ...

Overview Company News Filings

Relmada Therapeutics Inc. Conducted Annual Stockholders Meeting

Paul Edward Kelly, COO, Reports Acquisition of Relmada Therapeutics Inc. Common Shares

Relmada Therapeutics CFO Maged Shenouda Reports Acquisition of Common Shares

CEO Sergio Traversa Acquires Common Shares of Relmada Therapeutics Inc

Relmada Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Relmada Therapeutics Inc. Switches Audit Firms Amid Acquisition, No Disagreements Reported

BRIEF-Relmada Therapeutics Q1 Net Income USD -17.5 Million

Relmada Therapeutics Q1 Cash & Investments USD 27.1 Million

THOMSON REUTERS

Relmada Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Relmada Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Relmada Therapeutics Reports 'Positive' Phase 2 Data for Bladder Cancer Treatment

MT Newswires Live

Relmada Therapeutics presents initial Phase 2 NDV-01 data at AUA2025

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

Psychedelic: Clearmind completes clinical site initiations for AUD trial

Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data

Relmada Therapeutics To Present NDV-01 Data at AUA2025

Q4 2024 Relmada Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

Relmada Therapeutics Inc (RLMD) Q4 2024 Earnings Call Highlights: Strategic Acquisitions and ...

Relmada Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

BRIEF-Relmada Therapeutics Q4 EPS USD -0.62

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RLMD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RLMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLMD\",,,,,undefined,":{"symbol":"RLMD","market":"US","secType":"STK","nameCN":"Relmada Therapeutics, Inc.","latestPrice":0.8349,"timestamp":1749240000000,"preClose":0.82,"halted":0,"volume":477709,"hourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.8349,"latestTime":"19:29 EDT","volume":3427,"amount":2695.5146,"timestamp":1749252599473},"delay":0,"floatShares":24521688,"shares":33191622,"eps":-2.504245,"marketStatus":"Market Closed","change":0.0149,"latestTime":"06-06 16:00:00 EDT","open":0.8231,"high":0.9,"low":0.7862,"amount":403067.82862620003,"amplitude":0.13878,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.504245,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.82,"preHourTrading":{"tag":"盘前","latestPrice":0.8418,"preClose":0.82,"latestTime":"09:23 EDT","volume":4895,"amount":4115.397825,"timestamp":1749216203399},"postHourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.8349,"latestTime":"19:29 EDT","volume":3427,"amount":2695.5146,"timestamp":1749252599473},"volumeRatio":0.8666837930027224,"impliedVol":1.2563,"impliedVolPercentile":0.416},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLMD\",,,,,undefined,":{"symbol":"RLMD","floatShares":24521688,"roa":"-88.24%","roe":"-160.26%","lyrEps":-2.651505,"volumeRatio":0.8666837930027224,"shares":33191622,"dividePrice":0,"high":0.9,"amplitude":0.13878,"preClose":0.82,"low":0.7862,"week52Low":0.2404,"pbRate":"1.23","week52High":4.47,"institutionHeld":0,"latestPrice":0.8349,"eps":-2.504245,"divideRate":0,"volume":477709,"delay":0,"ttmEps":-2.504245,"open":0.8231,"prevYearClose":0.52,"prevWeekClose":0.75,"prevMonthClose":0.75,"prevQuarterClose":0.27,"fiveDayClose":0.75,"twentyDayClose":0.3633,"sixtyDayClose":0.27},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RLMD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538491709","title":"Relmada Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2538491709","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538491709?lang=en_us&edition=fundamental","pubTime":"2025-05-28 04:15","pubTimestamp":1748376958,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on May 23, 2025. During the meeting, stockholders elected John Glasspool as a Class I Director. The appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An amendment to the 2021 Equity Incentive Plan, increasing the number of shares available for issuance by 2,000,000, was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2025, and is solely r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nNDL2p8KTQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2537629883","title":"Paul Edward Kelly, COO, Reports Acquisition of Relmada Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2537629883","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537629883?lang=en_us&edition=fundamental","pubTime":"2025-05-21 06:04","pubTimestamp":1747778662,"startTime":"0","endTime":"0","summary":"Paul Edward Kelly, Chief Operating Officer and Director, reported an acquisition of common shares of Relmada Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL4NCgDr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2537626058","title":"Relmada Therapeutics CFO Maged Shenouda Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2537626058","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537626058?lang=en_us&edition=fundamental","pubTime":"2025-05-21 06:03","pubTimestamp":1747778623,"startTime":"0","endTime":"0","summary":"Maged Shenouda, the Chief Financial Officer of Relmada Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL7bGlCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2537626054","title":"CEO Sergio Traversa Acquires Common Shares of Relmada Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537626054","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537626054?lang=en_us&edition=fundamental","pubTime":"2025-05-21 06:02","pubTimestamp":1747778535,"startTime":"0","endTime":"0","summary":"Sergio Traversa, Chief Executive Officer of Relmada Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL3MX6HC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2535787382","title":"Relmada Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535787382","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535787382?lang=en_us&edition=fundamental","pubTime":"2025-05-13 05:00","pubTimestamp":1747083657,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryRelmada Therapeutics Inc RLMD.OQ reported a quarterly adjusted loss of 58 cents per share for the quarter ende","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nL8N3RK2PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0},{"id":"2535789769","title":"Relmada Therapeutics Inc. Switches Audit Firms Amid Acquisition, No Disagreements Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2535789769","media":"Reuters","labels":["merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535789769?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:07","pubTimestamp":1747080430,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc. has announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result of this acquisition, Relmada has dismissed Marcum as its independent registered public accounting firm, effective May 8, 2025, with the approval of the company's audit committee. Marcum's audit reports for fiscal years 2023 and 2024 did not contain adverse or qualified opinions, except for an explanatory note on the company's ability to continue as a going concern. Subsequently, CBIZ CPAs has been engaged as the new independent registered public accounting firm for the fiscal year ending December 31, 2025. The company noted that during the fiscal years 2023 and 2024, there were no disagreements or reportable events with Marcum concerning accounting principles, practices, or financial disclosures.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL8THyyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBZ","LU2065732104.USD","BK4123","BK4007","RLMD"],"gpt_icon":0},{"id":"2535178953","title":"BRIEF-Relmada Therapeutics Q1 Net Income USD -17.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535178953","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535178953?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:01","pubTimestamp":1747080106,"startTime":"0","endTime":"0","summary":"BRIEF-Relmada Therapeutics Q1 Net Income USD -17.5 Million\n\n\nMay 12 (Reuters) - Relmada Therapeutics Q1 cash & investments USD 27.1 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nPLXFED7FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2535789877","title":"Relmada Therapeutics Q1 Cash & Investments USD 27.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535789877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535789877?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:01","pubTimestamp":1747080061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nPLXFED7FF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2534461650","title":"Relmada Therapeutics Inc  expected to post a loss of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534461650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534461650?lang=en_us&edition=fundamental","pubTime":"2025-05-10 06:29","pubTimestamp":1746829747,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc  expected to post a loss of31cents a share - Earnings Preview Relmada Therapeutics Inc RLMD.OQ RLMD.O is expected to show no change in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH3N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0},{"id":"2532817166","title":"Relmada Therapeutics Inc  expected to post a loss of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532817166","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532817166?lang=en_us&edition=fundamental","pubTime":"2025-05-02 19:26","pubTimestamp":1746185179,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc  expected to post a loss of31cents a share - Earnings Preview Relmada Therapeutics Inc RLMD.OQ RLMD.O is expected to show no change in quarterly revenue when it reports  resul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA1CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0},{"id":"2531944254","title":"Relmada Therapeutics Reports 'Positive' Phase 2 Data for Bladder Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2531944254","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531944254?lang=en_us&edition=fundamental","pubTime":"2025-04-29 03:03","pubTimestamp":1745867006,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics  said Friday initial results from a phase 2 trial of NDV-01 for bladder cancer were positive.The study, which was presented at the annual meeting of the American Urology Association, showed that 90% of patients achieved high-grade disease-free status after treatment, supporting NDV-01's potential as a new therapy for non-muscle invasive bladder cancer, the company said.At the three-month mark, 85% of patients responded to treatment, and all patients with carcinoma in situ showed a complete response, it added.At six months, all seven patients who were evaluated remained disease-free, including one who needed a second treatment at three months, according to the company.The drug was generally safe and well-tolerated, with only mild side effects like urinary urgency and slight pain, which resolved within a day, Relmada said.Shares of the company were down over 41% in recent trading.Price: 0.38, Change: -0.27, Percent Change: -41.30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RLMD","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2531568922","title":"Relmada Therapeutics presents initial Phase 2 NDV-01 data at AUA2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531568922","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531568922?lang=en_us&edition=fundamental","pubTime":"2025-04-29 01:46","pubTimestamp":1745862373,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics (RLMD) announced that “positive” initial data from the Phase 2 study of NDV-01 showed that 90% of patients achieved high-grade...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/relmada-therapeutics-presents-initial-phase-2-ndv-01-data-at-aua2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/relmada-therapeutics-presents-initial-phase-2-ndv-01-data-at-aua2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4007","RLMD"],"gpt_icon":0},{"id":"2531558002","title":"Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531558002","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531558002?lang=en_us&edition=fundamental","pubTime":"2025-04-29 01:38","pubTimestamp":1745861880,"startTime":"0","endTime":"0","summary":"90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept for sustained-release “GEM/DOCE” formulation*. NDV-01 showed promising clinical activity in BCG-nave and BCG-unresponsive patients, with favorable overall tolerability. Data to be reviewed at Investor Event on April 28, 2025 at 4:30 PM ET. CORAL GABLES, Fla., April 28, 2025  -- Relmada Therapeutics, Inc. , a clinical-stage biotechnology company, today announced that positive initial data from the Phase 2 study of NDV-01 showed that 90% of patients achieved high-grade disease-free status at any time point following treatment, demonstrating strong clinical activity and supporting further development of NDV-01 for the treatment of non-muscle invasive bladder cancer . The data were presented today at the American Urology Association 2025  Annual Meeting with a data cutoff date of April 20, 2025. To register for the virtual Investor Event, click here.Overall: The trea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-presents-positive-initial-173800225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","ORR","BK4007","RLMD","CR","BK4161","BK4139"],"gpt_icon":0},{"id":"2530215933","title":"Psychedelic: Clearmind completes clinical site initiations for AUD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530215933","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530215933?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:30","pubTimestamp":1745595026,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing completion and clinical site partnerships.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.“AUD remains one of the most urgent and underserved public health challenges globally,” said Dr. Adi Zuloff-Shani, CEO. “With millions affected and current treatments often falling short, the study initiation for our FDA-approved CMND-100 trial marks a critical step toward potentially transforming the treatment landscape for alcoholism. We are honored to collaborate with world renowned institutions such as Yale and Johns Hopkins as we advance our mission to potentially provide safe, effective, and innovative solutions for individuals those suffering from alcoholism.”“Completing dosing of all participants in Part A of our 005 tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KTTA","AGNPF","NUMIF","BK4168","IXHL","BK4202","BK4547","PBM","SEEL","DRUG","CMPS","ALID","PHRRF","ATAI","PSYGF","MIRA","GHRS","SNPX","CYBN","ENTBF","MDXXF","RVVTF","BETRF","MNMD","MYCOF","ENVB","FLHLF","CMND","OPTHF","SPRC","BK4007","BK4539","QNTM","RLMD","SILO","NRXP","BK4139"],"gpt_icon":0},{"id":"2530501469","title":"Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2530501469","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530501469?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"April 28th AUA data presentation to highlight study in patients with high-gradenon-muscle invasive bladder cancer . Virtual event to be held on April 28, 2025 at 4:30 PM ET. CORAL GABLES, Fla., April 24, 2025  -- Relmada Therapeutics, Inc. , a clinical-stage biotechnology company, today announced it will host a virtual key opinion leader  event on Monday, April 28, 2025 at 4:30 PM ET. To register, please click here.The event will feature Boris Chertin, MD  and Yair Lotan, MD , who will join Relmada’s management to discuss topline efficacy and safety data from the Phase 2 study evaluating NDV-01 for the treatment of high-grade non-muscle invasive bladder cancer . The data will be presented at the American Urological Association meeting , on April 28, 2025 in Las Vegas, Nevada.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-host-kol-event-120000022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RLMD","BK4181","BK4139","BK4585","KOL","HST","BK4218","BK4007","BK4588","LENZ"],"gpt_icon":0},{"id":"2527159483","title":"Relmada Therapeutics To Present NDV-01 Data at AUA2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527159483","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527159483?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:30","pubTimestamp":1744630200,"startTime":"0","endTime":"0","summary":"CORAL GABLES, Fla., April 14, 2025  -- Relmada Therapeutics, Inc. , a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association , taking place from April 26-29th in Las Vegas.Prospective Open Label Study to Evaluate the Safety and Efficacy of Safety and Efficacy of intravesical sustained release Gemcitabine Docetaxel combination  in High Risk NMIBC: P2 on Apr 25. About NDV-01NDV-01 is an investigational, innovative sustained-release formulation of two complementary, well-established, chemotherapy agents, gemcitabine and docetaxel . It is designed for intravesical dosing and intended to be an in-office ready-to-use therapy that is administered rapidly and requires no anesthesia or new or dedicated equipment to employ. NDV-01 forms a spherical soft matrix within the bladder that sequesters drug and releases it as the matrix gradually dissolves.NDV-01 is protected by several patents that go out to 2038.The U.S. NMIBC market i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-present-ndv-01-113000967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","RLMD","LENZ","BK4139"],"gpt_icon":0},{"id":"2522679522","title":"Q4 2024 Relmada Therapeutics Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2522679522","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522679522?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:05","pubTimestamp":1743159928,"startTime":"0","endTime":"0","summary":"Brian Ritchie; Managing Director, LifeSci Advisors, LLC; Relmada Therapeutics Inc. Sergio Traversa; Chief Executive Officer, Director; Relmada Therapeutics Inc. Maged Shenouda; Chief Financial Officer; Relmada Therapeutics Inc. Greetings and welcome to the Relmada Therapeutics Incorporated quarter four 2024 financial results call.It is now my pleasure to introduce Brian Ritchie.Thank you. Brian, you may be good.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-relmada-therapeutics-inc-110528479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RLMD","LENZ"],"gpt_icon":0},{"id":"2522197895","title":"Relmada Therapeutics Inc (RLMD) Q4 2024 Earnings Call Highlights: Strategic Acquisitions and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2522197895","media":"GuruFocus.com","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522197895?lang=en_us&edition=fundamental","pubTime":"2025-03-28 15:03","pubTimestamp":1743145411,"startTime":"0","endTime":"0","summary":"Cash Equivalents and Short-term Investments: $44.9 million as of December 31, 2024, compared to $96.3 million as of December 31, 2023.Cash Used in Operations: $8.8 million for Q4 2024, compared to $10.2 million for Q4 2023.Research and Development Expense: $11 million for Q4 2024, compared to $14.7 million for Q4 2023.General and Administrative Expense: $8.1 million for Q4 2024, compared to $12.1 million for Q4 2023.Net Loss: $18.6 million or $0.62 per share for Q4 2024, compared to $25.1 million or $0.84 per share for Q4 2023.GuruFocus has detected 2 Warning Signs with RLMD.Relmada Therapeutics Inc  has successfully acquired rights to two promising candidates, NDVA1 for non-muscle invasive bladder cancer and Sopranoon for compulsion-related disorders, enhancing their product pipeline.Q: Can you explain the process involved in the acquisition deals, particularly for NDVO1, and why these companies chose Relmada over other bidders?A: Sergio Traversa, CEO, explained that the acquisition o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-inc-rlmd-q4-070331586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RLMD"],"gpt_icon":0},{"id":"2522534133","title":"Relmada Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522534133","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522534133?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:40","pubTimestamp":1743108002,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryRelmada Therapeutics Inc RLMD.OQ reported a quarterly adjusted loss of 62 cents per share for the quarter e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA247:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0},{"id":"2522539163","title":"BRIEF-Relmada Therapeutics Q4 EPS USD -0.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2522539163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522539163?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105946,"startTime":"0","endTime":"0","summary":"BRIEF-Relmada Therapeutics Q4 EPS USD -0.62\n\n\nMar 27 (Reuters) - Relmada Therapeutics Q4 net income USD -18.6 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX41B5DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":70,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RLMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"RLMD","fiscalQuarterEnding":"2025/03","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2025-03-27","symbol":"RLMD","fiscalQuarterEnding":"2024/12","expectedEps":-0.7,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2024-11-07","symbol":"RLMD","fiscalQuarterEnding":"2024/09","expectedEps":-0.65,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.72},{"market":"US","date":"2024-08-07","symbol":"RLMD","fiscalQuarterEnding":"2024/06","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2024-05-08","symbol":"RLMD","fiscalQuarterEnding":"2024/03","expectedEps":-0.9,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RLMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RLMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RLMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RLMD","date":"2025-06-06","current":-0.359489,"percent":0.899356,"low":-33.036996,"twenty":-7.947417,"median":-1.470281,"eighty":-0.659728,"high":-0.088966,"avg":-5.238401,"sd":6.818833,"marketCap":27217130},"quantilePoints":[{"date":"2020-06-12","current":-31.047373,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":713855179},{"date":"2020-06-19","current":-31.569567,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":725861685},{"date":"2020-06-26","current":-28.667758,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":659141987},{"date":"2020-07-02","current":-28.277765,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":650175103},{"date":"2020-07-10","current":-27.980313,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":643335953},{"date":"2020-07-17","current":-27.980313,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":643335953},{"date":"2020-07-24","current":-25.785779,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":592878232},{"date":"2020-07-31","current":-24.040727,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":552755224},{"date":"2020-08-07","current":-23.743276,"twenty":-5.700374,"median":-1.733041,"eighty":-0.357515,"marketCap":545916075},{"date":"2020-08-14","current":-19.888133,"twenty":-5.712286,"median":-1.733041,"eighty":-0.357515,"marketCap":596411270},{"date":"2020-08-21","current":-20.876662,"twenty":-5.737576,"median":-1.733041,"eighty":-0.357515,"marketCap":626055570},{"date":"2020-08-28","current":-18.637777,"twenty":-5.855718,"median":-1.733041,"eighty":-0.357515,"marketCap":558915236},{"date":"2020-09-04","current":-19.610276,"twenty":-5.948456,"median":-1.733041,"eighty":-0.357515,"marketCap":588078818},{"date":"2020-09-11","current":-19.36448,"twenty":-6.126741,"median":-1.733041,"eighty":-0.357515,"marketCap":580707803},{"date":"2020-09-18","current":-21.469779,"twenty":-6.279615,"median":-1.733041,"eighty":-0.357515,"marketCap":643842150},{"date":"2020-09-25","current":-19.66371,"twenty":-6.401962,"median":-1.733041,"eighty":-0.357515,"marketCap":589681212},{"date":"2020-10-02","current":-20.956813,"twenty":-6.49254,"median":-1.758166,"eighty":-0.357515,"marketCap":628459162},{"date":"2020-10-09","current":-20.860631,"twenty":-6.752577,"median":-1.818793,"eighty":-0.357515,"marketCap":625574851},{"date":"2020-10-16","current":-18.62709,"twenty":-13.145747,"median":-1.818793,"eighty":-0.357515,"marketCap":558594757},{"date":"2020-10-23","current":-17.814894,"twenty":-14.590145,"median":-1.853436,"eighty":-0.357515,"marketCap":534238359},{"date":"2020-10-30","current":-16.527134,"twenty":-14.890092,"median":-1.884167,"eighty":-0.357515,"marketCap":495620649},{"date":"2020-11-06","current":-17.040101,"twenty":-15.202709,"median":-1.905402,"eighty":-0.357515,"marketCap":511003637},{"date":"2020-11-13","current":-12.23902,"twenty":-15.348585,"median":-1.975556,"eighty":-0.357515,"marketCap":528986501},{"date":"2020-11-20","current":-13.854856,"twenty":-15.348585,"median":-2.000672,"eighty":-0.357515,"marketCap":598825063},{"date":"2020-11-27","current":-13.524173,"twenty":-15.348585,"median":-2.052637,"eighty":-0.357515,"marketCap":584532520},{"date":"2020-12-04","current":-13.152155,"twenty":-15.348585,"median":-2.07862,"eighty":-0.357515,"marketCap":568453410},{"date":"2020-12-11","current":-12.344237,"twenty":-15.348585,"median":-2.07862,"eighty":-0.357515,"marketCap":533534129},{"date":"2020-12-18","current":-12.663647,"twenty":-15.348585,"median":-2.160184,"eighty":-0.357515,"marketCap":547339426},{"date":"2020-12-24","current":-12.069921,"twenty":-15.348585,"median":-2.191878,"eighty":-0.357515,"marketCap":521677815},{"date":"2020-12-31","current":-12.051132,"twenty":-15.348585,"median":-2.251839,"eighty":-0.357515,"marketCap":520865738},{"date":"2021-01-08","current":-13.309981,"twenty":-15.348585,"median":-2.315052,"eighty":-0.357515,"marketCap":575274850},{"date":"2021-01-15","current":-13.854856,"twenty":-15.348585,"median":-2.359402,"eighty":-0.357515,"marketCap":598825063},{"date":"2021-01-22","current":-13.426472,"twenty":-15.348585,"median":-2.390413,"eighty":-0.361852,"marketCap":580309723},{"date":"2021-01-29","current":-12.280355,"twenty":-15.348585,"median":-2.511008,"eighty":-0.36481,"marketCap":530773069},{"date":"2021-02-05","current":-12.716255,"twenty":-15.348585,"median":-2.576427,"eighty":-0.370059,"marketCap":549613239},{"date":"2021-02-12","current":-13.704546,"twenty":-15.348585,"median":-2.617786,"eighty":-0.372159,"marketCap":592328453},{"date":"2021-02-19","current":-14.035229,"twenty":-15.348585,"median":-2.645672,"eighty":-0.372159,"marketCap":606620996},{"date":"2021-02-26","current":-12.528367,"twenty":-15.348585,"median":-2.728189,"eighty":-0.372159,"marketCap":541492476},{"date":"2021-03-05","current":-12.862808,"twenty":-15.354462,"median":-2.841532,"eighty":-0.371634,"marketCap":555947434},{"date":"2021-03-12","current":-13.779701,"twenty":-15.354462,"median":-2.841532,"eighty":-0.391734,"marketCap":595576758},{"date":"2021-03-19","current":-13.742123,"twenty":-15.354462,"median":-2.877762,"eighty":-0.424703,"marketCap":593952605},{"date":"2021-03-26","current":-9.271938,"twenty":-15.348585,"median":-2.890274,"eighty":-0.43007,"marketCap":551276015},{"date":"2021-04-01","current":-10.323333,"twenty":-15.348585,"median":-2.926862,"eighty":-0.438333,"marketCap":613788141},{"date":"2021-04-09","current":-9.923356,"twenty":-15.354462,"median":-2.987177,"eighty":-0.437014,"marketCap":590006991},{"date":"2021-04-16","current":-9.771253,"twenty":-15.354462,"median":-3.013299,"eighty":-0.437014,"marketCap":580963455},{"date":"2021-04-23","current":-10.376851,"twenty":-15.354462,"median":-3.039204,"eighty":-0.437014,"marketCap":616970126},{"date":"2021-04-30","current":-10.861329,"twenty":-15.354462,"median":-3.077954,"eighty":-0.437014,"marketCap":645775463},{"date":"2021-05-07","current":-10.236014,"twenty":-15.354462,"median":-3.096464,"eighty":-0.437014,"marketCap":608596482},{"date":"2021-05-14","current":-8.003248,"twenty":-15.354462,"median":-3.13772,"eighty":-0.437014,"marketCap":568216697},{"date":"2021-05-21","current":-8.968464,"twenty":-15.354462,"median":-3.169112,"eighty":-0.437014,"marketCap":636745344},{"date":"2021-05-28","current":-8.183043,"twenty":-15.354462,"median":-3.187536,"eighty":-0.437014,"marketCap":580981837},{"date":"2021-06-04","current":-7.12793,"twenty":-15.354462,"median":-3.192703,"eighty":-0.437014,"marketCap":506070620},{"date":"2021-06-11","current":-7.366868,"twenty":-15.354462,"median":-3.196717,"eighty":-0.437014,"marketCap":523034820},{"date":"2021-06-18","current":-7.310091,"twenty":-15.354462,"median":-3.215186,"eighty":-0.437014,"marketCap":519003723},{"date":"2021-06-25","current":-8.126266,"twenty":-15.354462,"median":-3.245915,"eighty":-0.437014,"marketCap":576950740},{"date":"2021-07-02","current":-7.71463,"twenty":-15.354462,"median":-3.278609,"eighty":-0.437014,"marketCap":547725288},{"date":"2021-07-09","current":-8.097877,"twenty":-15.354462,"median":-3.296823,"eighty":-0.437014,"marketCap":574935192},{"date":"2021-07-16","current":-7.373965,"twenty":-15.354462,"median":-3.315038,"eighty":-0.443169,"marketCap":523538707},{"date":"2021-07-23","current":-6.127228,"twenty":-15.354462,"median":-3.370574,"eighty":-0.443169,"marketCap":435022538},{"date":"2021-07-30","current":-6.150886,"twenty":-15.354462,"median":-3.371104,"eighty":-0.555367,"marketCap":436702162},{"date":"2021-08-06","current":-5.568917,"twenty":-15.354462,"median":-3.380611,"eighty":-0.578507,"marketCap":395383418},{"date":"2021-08-13","current":-4.61934,"twenty":-15.354462,"median":-3.397035,"eighty":-0.605119,"marketCap":399257730},{"date":"2021-08-20","current":-4.534433,"twenty":-15.354462,"median":-3.424324,"eighty":-0.659499,"marketCap":391919075},{"date":"2021-08-27","current":-4.890234,"twenty":-15.354462,"median":-3.448899,"eighty":-0.746275,"marketCap":422671531},{"date":"2021-09-03","current":-4.932687,"twenty":-15.354462,"median":-3.460753,"eighty":-0.821481,"marketCap":426340858},{"date":"2021-09-10","current":-5.260185,"twenty":-15.354462,"median":-3.485622,"eighty":-0.850406,"marketCap":454647095},{"date":"2021-09-17","current":-5.571511,"twenty":-15.354462,"median":-3.500762,"eighty":-0.850406,"marketCap":481555494},{"date":"2021-09-24","current":-5.882836,"twenty":-15.354462,"median":-3.51567,"eighty":-0.850406,"marketCap":508463892},{"date":"2021-10-01","current":-5.40574,"twenty":-15.354462,"median":-3.578556,"eighty":-0.970791,"marketCap":467227645},{"date":"2021-10-08","current":-5.290509,"twenty":-15.354462,"median":-3.584692,"eighty":-1.000536,"marketCap":457268043},{"date":"2021-10-15","current":-4.777025,"twenty":-15.354462,"median":-3.605816,"eighty":-1.014057,"marketCap":412886659},{"date":"2021-10-22","current":-4.815435,"twenty":-15.354462,"median":-3.628468,"eighty":-1.022224,"marketCap":416206526},{"date":"2021-10-29","current":-4.744679,"twenty":-15.354462,"median":-3.668784,"eighty":-1.054619,"marketCap":410090981},{"date":"2021-11-05","current":-5.314768,"twenty":-15.354462,"median":-3.690124,"eighty":-1.081661,"marketCap":459364801},{"date":"2021-11-12","current":-3.567592,"twenty":-15.354462,"median":-3.789733,"eighty":-1.415629,"marketCap":400053540},{"date":"2021-11-19","current":-3.187695,"twenty":-15.354462,"median":-3.789733,"eighty":-1.448079,"marketCap":357453623},{"date":"2021-11-26","current":-2.943811,"twenty":-15.354462,"median":-3.789733,"eighty":-1.458021,"marketCap":330105528},{"date":"2021-12-03","current":-2.646772,"twenty":-15.354462,"median":-3.789733,"eighty":-1.458229,"marketCap":296796951},{"date":"2021-12-10","current":-4.42415,"twenty":-15.354462,"median":-3.795557,"eighty":-1.477343,"marketCap":496104008},{"date":"2021-12-17","current":-4.705268,"twenty":-15.354462,"median":-3.795557,"eighty":-1.499231,"marketCap":527627378},{"date":"2021-12-23","current":-5.501431,"twenty":-15.354462,"median":-3.909674,"eighty":-1.532958,"marketCap":616905369},{"date":"2021-12-31","current":-5.570662,"twenty":-15.354462,"median":-4.004888,"eighty":-1.552453,"marketCap":624668672},{"date":"2022-01-07","current":-5.170108,"twenty":-15.348585,"median":-4.217285,"eighty":-1.558965,"marketCap":579752416},{"date":"2022-01-14","current":-4.91049,"twenty":-15.348585,"median":-4.421677,"eighty":-1.560442,"marketCap":550640028},{"date":"2022-01-21","current":-4.591531,"twenty":-15.348585,"median":-4.551617,"eighty":-1.56326,"marketCap":514873379},{"date":"2022-01-28","current":-4.32944,"twenty":-15.348585,"median":-4.580166,"eighty":-1.579649,"marketCap":485483730},{"date":"2022-02-04","current":-4.195923,"twenty":-15.348585,"median":-4.580166,"eighty":-1.584662,"marketCap":470511645},{"date":"2022-02-11","current":-4.569278,"twenty":-15.348585,"median":-4.605436,"eighty":-1.606919,"marketCap":512378032},{"date":"2022-02-18","current":-4.517354,"twenty":-15.348585,"median":-4.634752,"eighty":-1.627238,"marketCap":506555554},{"date":"2022-02-25","current":-5.081097,"twenty":-15.348585,"median":-4.649032,"eighty":-1.637901,"marketCap":569771026},{"date":"2022-03-04","current":-5.093459,"twenty":-15.348585,"median":-4.686724,"eighty":-1.645574,"marketCap":571157330},{"date":"2022-03-11","current":-5.498958,"twenty":-15.348585,"median":-4.748722,"eighty":-1.671902,"marketCap":616628108},{"date":"2022-03-18","current":-5.953908,"twenty":-15.348585,"median":-4.779046,"eighty":-1.671902,"marketCap":667644102},{"date":"2022-03-25","current":-6.013944,"twenty":-15.348585,"median":-4.795535,"eighty":-1.724543,"marketCap":756264367},{"date":"2022-04-01","current":-6.866406,"twenty":-15.348585,"median":-4.819018,"eighty":-1.749505,"marketCap":863463006},{"date":"2022-04-08","current":-6.209434,"twenty":-15.348585,"median":-4.84677,"eighty":-1.815329,"marketCap":780847514},{"date":"2022-04-14","current":-6.092407,"twenty":-15.348585,"median":-4.910514,"eighty":-1.818793,"marketCap":766131202},{"date":"2022-04-22","current":-5.727284,"twenty":-15.348585,"median":-4.93957,"eighty":-1.836115,"marketCap":720216309},{"date":"2022-04-29","current":-5.877078,"twenty":-15.348585,"median":-4.99703,"eighty":-1.869901,"marketCap":739053188},{"date":"2022-05-06","current":-4.443703,"twenty":-15.348585,"median":-5.010782,"eighty":-1.905402,"marketCap":636704471},{"date":"2022-05-13","current":-4.144386,"twenty":-15.348585,"median":-5.010782,"eighty":-1.940046,"marketCap":593817642},{"date":"2022-05-20","current":-4.20718,"twenty":-15.348585,"median":-5.010782,"eighty":-1.992011,"marketCap":602814879},{"date":"2022-05-27","current":-4.148572,"twenty":-15.348585,"median":-5.010782,"eighty":-2.040855,"marketCap":594417457},{"date":"2022-06-03","current":-4.058568,"twenty":-15.348585,"median":-5.010782,"eighty":-2.078009,"marketCap":581521418},{"date":"2022-06-10","current":-3.767624,"twenty":-15.348585,"median":-5.010782,"eighty":-2.07862,"marketCap":539834220},{"date":"2022-06-17","current":-3.830418,"twenty":-15.348585,"median":-5.010782,"eighty":-2.107186,"marketCap":548831457},{"date":"2022-06-24","current":-4.112989,"twenty":-15.354462,"median":-5.011529,"eighty":-2.165229,"marketCap":589319023},{"date":"2022-07-01","current":-3.830418,"twenty":-15.354462,"median":-5.011529,"eighty":-2.251839,"marketCap":548831457},{"date":"2022-07-08","current":-3.958098,"twenty":-15.354462,"median":-5.011529,"eighty":-2.306182,"marketCap":567125838},{"date":"2022-07-15","current":-4.70325,"twenty":-15.354462,"median":-5.011529,"eighty":-2.355854,"marketCap":673893051},{"date":"2022-07-22","current":-4.962798,"twenty":-15.354462,"median":-5.02511,"eighty":-2.393877,"marketCap":711081630},{"date":"2022-07-29","current":-5.358398,"twenty":-15.354462,"median":-5.051511,"eighty":-2.514569,"marketCap":767764224},{"date":"2022-08-05","current":-5.479799,"twenty":-15.354462,"median":-5.071206,"eighty":-2.577332,"marketCap":785158882},{"date":"2022-08-12","current":-5.583625,"twenty":-15.354462,"median":-5.085412,"eighty":-2.618223,"marketCap":874761073},{"date":"2022-08-19","current":-5.566356,"twenty":-15.354462,"median":-5.130803,"eighty":-2.648853,"marketCap":872055627},{"date":"2022-08-26","current":-5.658457,"twenty":-15.354462,"median":-5.14291,"eighty":-2.717642,"marketCap":886484675},{"date":"2022-09-02","current":-5.702589,"twenty":-15.354462,"median":-5.161645,"eighty":-2.789962,"marketCap":893398594},{"date":"2022-09-09","current":-6.118962,"twenty":-15.354462,"median":-5.168988,"eighty":-2.83992,"marketCap":958629919},{"date":"2022-09-16","current":-6.537255,"twenty":-15.354462,"median":-5.170108,"eighty":-2.841532,"marketCap":1024161848},{"date":"2022-09-23","current":-6.120881,"twenty":-15.354462,"median":-5.21571,"eighty":-2.8635,"marketCap":958930524},{"date":"2022-09-30","current":-7.103292,"twenty":-15.354462,"median":-5.232811,"eighty":-2.877762,"marketCap":1112840376},{"date":"2022-10-07","current":-6.569874,"twenty":-15.354462,"median":-5.260185,"eighty":-2.877762,"marketCap":1029272136},{"date":"2022-10-14","current":-1.189638,"twenty":-15.354462,"median":-5.278901,"eighty":-2.870556,"marketCap":186375211},{"date":"2022-10-21","current":-1.345059,"twenty":-15.354462,"median":-5.278901,"eighty":-2.841532,"marketCap":210724231},{"date":"2022-10-28","current":-1.256795,"twenty":-15.354462,"median":-5.278901,"eighty":-2.841532,"marketCap":196896392},{"date":"2022-11-04","current":-1.220339,"twenty":-15.354462,"median":-5.278901,"eighty":-2.789962,"marketCap":191184894},{"date":"2022-11-11","current":-1.245325,"twenty":-15.354462,"median":-5.278901,"eighty":-2.717642,"marketCap":191129939},{"date":"2022-11-18","current":-1.164918,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":178789265},{"date":"2022-11-25","current":-1.029599,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":158020815},{"date":"2022-12-02","current":-0.902125,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":138456333},{"date":"2022-12-09","current":-0.525586,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":80665864},{"date":"2022-12-16","current":-0.660905,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":101434314},{"date":"2022-12-23","current":-0.590304,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":90598601},{"date":"2022-12-30","current":-0.684438,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":105046218},{"date":"2023-01-06","current":-0.645216,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":99026377},{"date":"2023-01-13","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-01-20","current":-0.933504,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":143272206},{"date":"2023-01-27","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-02-03","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-02-10","current":-0.733467,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":112571019},{"date":"2023-02-17","current":-0.719739,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":110464075},{"date":"2023-02-24","current":-0.651099,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":99929353},{"date":"2023-03-03","current":-0.698166,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":107153162},{"date":"2023-03-10","current":-0.56677,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":86986696},{"date":"2023-03-17","current":-0.484402,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":74345031},{"date":"2023-03-24","current":-0.435071,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":68325190},{"date":"2023-03-31","current":-0.433154,"twenty":-15.348585,"median":-5.270935,"eighty":-2.684884,"marketCap":68024198},{"date":"2023-04-06","current":-0.425488,"twenty":-15.348585,"median":-5.270935,"eighty":-2.684884,"marketCap":66820230},{"date":"2023-04-14","current":-0.490653,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":77053959},{"date":"2023-04-21","current":-0.511735,"twenty":-15.354462,"median":-5.278901,"eighty":-2.644504,"marketCap":80364872},{"date":"2023-04-28","current":-0.525152,"twenty":-15.354462,"median":-5.278901,"eighty":-2.598617,"marketCap":82471816},{"date":"2023-05-05","current":-0.58265,"twenty":-15.354462,"median":-5.278901,"eighty":-2.528919,"marketCap":91501577},{"date":"2023-05-12","current":-0.664355,"twenty":-15.354462,"median":-5.278901,"eighty":-2.410667,"marketCap":95414473},{"date":"2023-05-19","current":-0.651781,"twenty":-15.354462,"median":-5.278901,"eighty":-2.359402,"marketCap":93608521},{"date":"2023-05-26","current":-0.595195,"twenty":-15.354462,"median":-5.278901,"eighty":-2.316826,"marketCap":85481736},{"date":"2023-06-02","current":-0.570046,"twenty":-15.354462,"median":-5.278901,"eighty":-2.284445,"marketCap":81869832},{"date":"2023-06-09","current":-0.588908,"twenty":-15.354462,"median":-5.278901,"eighty":-2.165229,"marketCap":84578760},{"date":"2023-06-16","current":-0.534418,"twenty":-15.354462,"median":-5.278901,"eighty":-2.143555,"marketCap":76752967},{"date":"2023-06-23","current":-0.536514,"twenty":-15.360338,"median":-5.282659,"eighty":-2.165229,"marketCap":77053959},{"date":"2023-06-30","current":-0.521844,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":74947015},{"date":"2023-07-07","current":-0.52394,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":75248007},{"date":"2023-07-14","current":-0.591004,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":84879752},{"date":"2023-07-21","current":-0.62244,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":89394632},{"date":"2023-07-28","current":-0.519748,"twenty":-15.366215,"median":-5.286416,"eighty":-2.085105,"marketCap":74646023},{"date":"2023-08-04","current":-0.546993,"twenty":-15.366215,"median":-5.286416,"eighty":-2.022579,"marketCap":78558919},{"date":"2023-08-11","current":-0.66738,"twenty":-15.366215,"median":-5.286416,"eighty":-1.995475,"marketCap":86083720},{"date":"2023-08-18","current":-0.665046,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":85782728},{"date":"2023-08-25","current":-0.744385,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":96016457},{"date":"2023-09-01","current":-0.788722,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":101735306},{"date":"2023-09-08","current":-0.828391,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":106852170},{"date":"2023-09-15","current":-0.772387,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":99628361},{"date":"2023-09-22","current":-0.669713,"twenty":-15.366215,"median":-5.286416,"eighty":-1.912331,"marketCap":86384712},{"date":"2023-09-29","current":-0.686048,"twenty":-15.445182,"median":-5.286416,"eighty":-1.627406,"marketCap":88491656},{"date":"2023-10-06","current":-0.700049,"twenty":-15.518272,"median":-5.28644,"eighty":-1.900782,"marketCap":90297609},{"date":"2023-10-13","current":-0.746719,"twenty":-15.518272,"median":-5.28644,"eighty":-1.878374,"marketCap":96317449},{"date":"2023-10-20","current":-0.723384,"twenty":-15.518272,"median":-5.28644,"eighty":-1.444835,"marketCap":93307529},{"date":"2023-10-27","current":-0.732718,"twenty":-15.783249,"median":-5.288487,"eighty":-1.358874,"marketCap":94511497},{"date":"2023-11-03","current":-0.711716,"twenty":-15.783249,"median":-5.288487,"eighty":-1.26447,"marketCap":91802569},{"date":"2023-11-10","current":-0.806631,"twenty":-15.783249,"median":-5.288487,"eighty":-1.225327,"marketCap":89996616},{"date":"2023-11-17","current":-0.79584,"twenty":-15.783249,"median":-5.288487,"eighty":-1.187047,"marketCap":88792648},{"date":"2023-11-24","current":-0.782351,"twenty":-15.783249,"median":-5.288487,"eighty":-1.150072,"marketCap":87287688},{"date":"2023-11-30","current":-0.677139,"twenty":-15.828956,"median":-5.290509,"eighty":-1.129618,"marketCap":75548999},{"date":"2023-12-08","current":-0.690627,"twenty":-15.874664,"median":-5.294552,"eighty":-1.029599,"marketCap":77053959},{"date":"2023-12-15","current":-0.674441,"twenty":-15.920371,"median":-5.298596,"eighty":-0.904086,"marketCap":75248007},{"date":"2023-12-22","current":-0.79584,"twenty":-15.920371,"median":-5.298596,"eighty":-0.874579,"marketCap":88792648},{"date":"2023-12-29","current":-1.022452,"twenty":-15.966078,"median":-5.300095,"eighty":-0.866825,"marketCap":114075979},{"date":"2024-01-05","current":-0.834958,"twenty":-16.008223,"median":-5.301594,"eighty":-0.865648,"marketCap":93157033},{"date":"2024-01-12","current":-0.89296,"twenty":-16.008223,"median":-5.301594,"eighty":-0.865648,"marketCap":99628361},{"date":"2024-01-19","current":-0.919937,"twenty":-16.050367,"median":-5.303846,"eighty":-0.860157,"marketCap":102638282},{"date":"2024-01-26","current":-0.97659,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":108959114},{"date":"2024-02-02","current":-1.23018,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":137252365},{"date":"2024-02-09","current":-1.413628,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":157719823},{"date":"2024-02-16","current":-1.421721,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":158622799},{"date":"2024-02-23","current":-1.494561,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":166749584},{"date":"2024-03-01","current":-1.65238,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":184357618},{"date":"2024-03-08","current":-1.718475,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":191731923},{"date":"2024-03-15","current":-1.356975,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":151398991},{"date":"2024-03-22","current":-1.423315,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":140611781},{"date":"2024-03-28","current":-1.401935,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":138499587},{"date":"2024-04-05","current":-1.432478,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":141517007},{"date":"2024-04-12","current":-1.423315,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":140611781},{"date":"2024-04-19","current":-1.313359,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":129749068},{"date":"2024-04-26","current":-1.1301,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":111644547},{"date":"2024-05-03","current":-1.136209,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":112248031},{"date":"2024-05-10","current":-1.21595,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":114661967},{"date":"2024-05-17","current":-1.116754,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":105307964},{"date":"2024-05-24","current":-0.995159,"twenty":-15.966078,"median":-5.288487,"eighty":-0.860941,"marketCap":93841768},{"date":"2024-05-31","current":-0.95996,"twenty":-15.966078,"median":-5.288487,"eighty":-0.860941,"marketCap":90522606},{"date":"2024-06-07","current":-0.943961,"twenty":-15.966078,"median":-5.282683,"eighty":-0.860941,"marketCap":89013895},{"date":"2024-06-14","current":-0.96316,"twenty":-15.966078,"median":-5.258417,"eighty":-0.860941,"marketCap":90824348},{"date":"2024-06-21","current":-0.96956,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":91427832},{"date":"2024-06-28","current":-0.95996,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":90522606},{"date":"2024-07-05","current":-0.96636,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":91126090},{"date":"2024-07-12","current":-1.299146,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":122507260},{"date":"2024-07-19","current":-1.331145,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":125524680},{"date":"2024-07-26","current":-1.257548,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":118584613},{"date":"2024-08-02","current":-1.151952,"twenty":-16.008223,"median":-5.232811,"eighty":-0.860549,"marketCap":108627127},{"date":"2024-08-09","current":-0.799884,"twenty":-16.008223,"median":-5.219754,"eighty":-0.854534,"marketCap":69400664},{"date":"2024-08-16","current":-0.869439,"twenty":-16.008223,"median":-5.204724,"eighty":-0.846337,"marketCap":75435505},{"date":"2024-08-23","current":-0.963338,"twenty":-16.008223,"median":-5.170108,"eighty":-0.846337,"marketCap":83582539},{"date":"2024-08-30","current":-0.973771,"twenty":-16.008223,"median":-5.149086,"eighty":-0.846337,"marketCap":84487765},{"date":"2024-09-06","current":-0.834661,"twenty":-16.008223,"median":-5.140911,"eighty":-0.842956,"marketCap":72418084},{"date":"2024-09-13","current":-1.074626,"twenty":-16.008223,"median":-5.104523,"eighty":-0.842956,"marketCap":93238284},{"date":"2024-09-20","current":-1.220692,"twenty":-16.008223,"median":-5.07622,"eighty":-0.842956,"marketCap":105911449},{"date":"2024-09-27","current":-1.172003,"twenty":-16.008223,"median":-5.056005,"eighty":-0.842956,"marketCap":101687060},{"date":"2024-10-04","current":-1.210259,"twenty":-16.008223,"median":-5.004447,"eighty":-0.842956,"marketCap":105006222},{"date":"2024-10-11","current":-1.151137,"twenty":-16.008223,"median":-4.962798,"eighty":-0.842956,"marketCap":99876608},{"date":"2024-10-18","current":-1.255469,"twenty":-16.008223,"median":-4.912471,"eighty":-0.842956,"marketCap":108928869},{"date":"2024-10-25","current":-1.258947,"twenty":-15.783249,"median":-4.85991,"eighty":-0.842956,"marketCap":109230611},{"date":"2024-11-01","current":-1.213736,"twenty":-15.402661,"median":-4.815435,"eighty":-0.842956,"marketCap":105307964},{"date":"2024-11-08","current":-1.144345,"twenty":-15.202709,"median":-4.785111,"eighty":-0.842956,"marketCap":98971382},{"date":"2024-11-15","current":-1.050146,"twenty":-14.670355,"median":-4.777025,"eighty":-0.842956,"marketCap":90824348},{"date":"2024-11-22","current":-0.97688,"twenty":-14.055521,"median":-4.73255,"eighty":-0.842956,"marketCap":84487765},{"date":"2024-11-29","current":-1.053635,"twenty":-13.770683,"median":-4.70325,"eighty":-0.842956,"marketCap":91126090},{"date":"2024-12-06","current":-0.159615,"twenty":-13.72108,"median":-4.649664,"eighty":-0.834899,"marketCap":13804697},{"date":"2024-12-13","current":-0.128041,"twenty":-13.506136,"median":-4.638411,"eighty":-0.827185,"marketCap":11073932},{"date":"2024-12-20","current":-0.126611,"twenty":-13.359584,"median":-4.586586,"eighty":-0.820859,"marketCap":10950217},{"date":"2024-12-27","current":-0.133623,"twenty":-13.288938,"median":-4.559388,"eighty":-0.809644,"marketCap":11556719},{"date":"2025-01-03","current":-0.164011,"twenty":-13.246851,"median":-4.534433,"eighty":-0.807718,"marketCap":14184892},{"date":"2025-01-10","current":-0.14388,"twenty":-13.18372,"median":-4.502605,"eighty":-0.799884,"marketCap":12443840},{"date":"2025-01-17","current":-0.130413,"twenty":-13.152155,"median":-4.426601,"eighty":-0.79584,"marketCap":11279116},{"date":"2025-01-24","current":-0.135786,"twenty":-13.119839,"median":-4.312651,"eighty":-0.79469,"marketCap":11743799},{"date":"2025-01-31","current":-0.121761,"twenty":-13.103304,"median":-4.191086,"eighty":-0.786174,"marketCap":10530796},{"date":"2025-02-07","current":-0.107841,"twenty":-12.950739,"median":-4.125642,"eighty":-0.776093,"marketCap":9326845},{"date":"2025-02-14","current":-0.116144,"twenty":-12.744814,"median":-4.0795,"eighty":-0.760749,"marketCap":10044991},{"date":"2025-02-21","current":-0.102921,"twenty":-12.680181,"median":-4.040776,"eighty":-0.74394,"marketCap":8901389},{"date":"2025-02-28","current":-0.09071,"twenty":-12.574212,"median":-3.996821,"eighty":-0.734417,"marketCap":7845292},{"date":"2025-03-07","current":-0.099956,"twenty":-12.358517,"median":-3.916236,"eighty":-0.728984,"marketCap":8644908},{"date":"2025-03-14","current":-0.102119,"twenty":-12.269833,"median":-3.868094,"eighty":-0.723384,"marketCap":8831988},{"date":"2025-03-21","current":-0.103375,"twenty":-11.885039,"median":-3.775996,"eighty":-0.718562,"marketCap":8940616},{"date":"2025-03-28","current":-0.123131,"twenty":-10.929494,"median":-3.547268,"eighty":-0.710316,"marketCap":9847954},{"date":"2025-04-04","current":-0.113047,"twenty":-10.655144,"median":-3.353412,"eighty":-0.698919,"marketCap":9041397},{"date":"2025-04-11","current":-0.122633,"twenty":-10.448396,"median":-3.001655,"eighty":-0.697715,"marketCap":9808124},{"date":"2025-04-17","current":-0.120268,"twenty":-10.281082,"median":-2.848446,"eighty":-0.693515,"marketCap":9618932},{"date":"2025-04-25","current":-0.267718,"twenty":-9.997718,"median":-2.646772,"eighty":-0.685082,"marketCap":21411915},{"date":"2025-05-02","current":-0.151517,"twenty":-9.811335,"median":-1.71308,"eighty":-0.677139,"marketCap":12118261},{"date":"2025-05-09","current":-0.174093,"twenty":-9.402585,"median":-1.607867,"eighty":-0.674441,"marketCap":13923885},{"date":"2025-05-16","current":-0.202103,"twenty":-9.002788,"median":-1.53233,"eighty":-0.670112,"marketCap":15301337},{"date":"2025-05-23","current":-0.269616,"twenty":-8.533644,"median":-1.494561,"eighty":-0.666194,"marketCap":20412847},{"date":"2025-05-30","current":-0.316394,"twenty":-8.208593,"median":-1.489165,"eighty":-0.664827,"marketCap":23954393},{"date":"2025-06-06","current":-0.359489,"twenty":-7.947417,"median":-1.470281,"eighty":-0.659728,"marketCap":27217130}],"updateTime":1749302239711}}}